M/23/030 Novo Group/Kelvin Holdco (Ellab)

Transaction details

The proposed acquisition by Echo BidCo A/S, an indirect wholly owned subsidiary of Novo Holdings A/S, of sole control of Kelvin HoldCo A/S, trading as Ellab, has been cleared by the Competition and Consumer Protection Commission.

 

Notification date Decision date
Tuesday July 11, 2023 Friday, July 28, 2023
Parties Involved Business activities
Echo BidCo A/S

Echo BidCo A/S is a wholly-owned subsidiary of Novo Holdings A/S, an indirect subsidiary of the Novo Nordisk Foundation. The Novo Nordisk Foundation is an established enterprise foundation, headquartered in Hellerup, Denmark. The Foundation's vision is to contribute to research and development that improves the lives of people and the sustainability of the planet. Novo Holdings A/S is responsible for managing the assets of the Novo Nordisk Foundation through investments in the life sciences and related area, and through investments in companies dedicated to medical and scientific research.

Ellab

Ellab provides validation and monitoring solutions and services used for measuring and documenting parameters such as temperature, pressure and carbon dioxide in biotech and pharma processes. Ellab is a portfolio company of the investment fund EQT Mid Market Europe, which is an EQT investment fund.

Economic sector Media merger
Healthcare/Other Services No
Submissions from third parties due by:
Phase 1 Phase 2
Thursday, July 27, 2023
Current status: Completed
Cleared (Phase 1)
Authorised Officer Assigned Contact Details
Lewis O'Shea

lewisoshea@ccpc.ie

Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Haven’t found what you’re looking for?